MP-6-2
Cigarette smoking is the principal risk factors in young men with erectile dysfunktion N. Mondaini, Italy; G. Del Popolo, G. Lombardi, A. Natali, M. Rizzo, G. Vignolini Purpose Clinical and basic science studies provide strong indirect evidence that smoking may affect penile erection. The objective of this retrospective research was to investigate the role of smoking for ED in order to obtain some insight into the prevention of ED. Materials and Methods We reviewed the data from 860 male patients aged 18 to 44 visited during the period of January 1999 to December 2002. The patients were divided into 3 groups:smokers, never smokers,former smokers. All patients underwent medical history, IIEF 5 questionaire. physical examination, serum levels of glucose, cholesterol, prolactin and free testosterone.Our data were compared with ISTAT (Italian Institute of Stathistics) data on the italian population and smoking. Results The distribuition of the 860 patients ,mean age 32,4 years old (range 18-44),in the 3 groups is: smokers 460 (53,5%), never smokers 320 (37,2%),former smokers 80 (9,3%). Current smokers in our series are 460 (53,5%) in comparison to 34,7% of male current smokers in Italy in the same range of year . 337/860 are the patients who smoked more than 20 cigarettes/day (39,2%) and this data is extremely interesting because comparing the same aged men through ISTAT only 4% are heavy smokers. Conclusions Analysing the incidence of heavy smoking in middleaged patients affected by E.D with the whole Italian population by means of ISTAT, taking into account males with the same age range we showed that the data of our population (sample) to the whole Italian middle-aged patients is 39,2% versus 4% so it explains the need for education within a comprehensive smoking cessation program should be reserved especially for young smokers, in order to be aware of the effect of tobacco on erectile function.
MP-6-3
Risk factors in diabetic patients with ED: A new risk factor homocysteinemia A. Esen, Turkey; L. Argun, S.-Ç . Aytaç -Gu¨lcu¨, Ö . Demir, T. Demir, S.-Y. Mustafa-Seç il, A. Ç o¨mlekç i
Introduction: Nitric oxide (NO) plays important role in endothelium dependent vasodilator responses in diabetes and erectile dysfunction (ED). Hyperhomocysteinemia which is more prevalent in diabetic patients has been shown to impair NO generation. We have investigated classical risk factors and homocysteinemia (Hcys) in our diabetic patients with ED and without ED. Method: Sixty-two diabetic patients who were verified by the IIEF questionaire for erectile quality were included in study. 32 diabetic patients with ED (mean age 54.2277.33) and 30 diabetic patients without ED (mean age 53.5876.53) were evaluated for fasting plasma glucose, postprandial plasma glucose, HbA1c, total cholesterol, triglyceride, HDL cholesterol, LDL cholesterol, apo-A, apo B-100, vitamine B12, folic acid and plasma Hcys levels. Color duplex penil ultrasound was used to detect vascular abnormalities in ED patients after papaverin injection. Results There was no significant difference in age, diabetes duration, body mass index, waist-hip ratio, total cholesterol, triglyceride, HDL cholesterol, LDL cholesterol, apo-A, apoB-100 levels between these two grups (p40.05). Fasting plasma glucose, postprandial plasma glucose and HbA1c levels were significantly higher in diabetic patients with ED (po 0.05). Although Hcys levels in diabetic patients with ED were slightly higher than the patients without ED, it was not at statistical significance (p40.05). There were no statistically significancy correlation with Hcys and doppler ultrasound parameters. Logistic regression analysis revealed that HbA1c (po0.01), smoking (po0.01), and Hcys (po0.05) were the main determinants in ED. Conclusions These data suggest that classical risk factors poor metabolic control, smoking are important in ED generation in diabetic patients. In addition Hcys which is an important risk factor in atherogenesis, seems to be important in ED generation.
MP-6-4
Prevalence of erectile dysfunction in an outpatient population of men with diabetes -Relationship to glycemic control Results ED was present in 40% of males with type 1 and 56% of males with type 2 diabetes. 17% of males with type 1 and 28% of males with type 2 diabetes had a severe degree of ED. ED increased with age in both types of diabetes (po0.001). High HbA1c was significantly associated with ED in males with type 1 (p¼0.018) but not in males with type 2 diabetes. Only 39 (19%) of the participants had received treatment for ED, the most commonly used drug being sildenafil. Conclusions The prevalence of ED in an Icelandic outpatient population of males with diabetes is comparable to that reported from other countries. ED was associated with poor glycemic control in type 1 and with age in both types of diabetes. Less than half of those with ED had received treatment for the problem.
MP-6-5
Prostate cancer under hormonal treatment: Lower urinary tract symptoms but not erectile dysfunction affects health related quality of life Objective To investigate the impact of erectile dysfunction (ED) and lower urinary tract symptoms (LUTS) on health related quality of life (HRQoL) and psychological well-being in men with locally extensive non metastatic prostate cancer under complete androgen suppression. Design and Methods Forty seven men (mean age 70.5776.6 years) included in the study. HRQoL was measured with MOS-SF-36 and psychopathology with GHQ-28. IIEF was used to estimate erectile function and IPSS for LUTS. The impact of ED and LUTS on HRQoL was investigated. Results All men had severe erectile dysfunction (IIEF mean¼8.5773.2). Their total HRQoL and psychological functioning scores appeared normal. No significant correlation was found between IIEF SF-36 and GHQ. On the other hand correlation found between IPSS and the mental component summary (MCS) of po0.05 ) and the Likert score of GHQ (r¼-0,483, po0.001). According to IPSS scores (mean 8.5577.8), 25 men had mild, 17 moderate and 5 severe LUTS. SF-36 and GHQ scores were normal for the mild and moderate LUTS subgroups, but significantly affected in the severe LUTS subgroup: HRQoL appeared lower (F(2, 44)¼8.42, po0.001) and psychopathology was evident (Likert-GHQ scoring F(2,44)¼6.33, po0.001). Conclusions ED in prostate cancer patients under complete androgen suppression does not affect HRQoL or their psychological functioning. In contrast, severe -but not mild and moderate -LUTS adversely affects HRQoL and well-being. Possibly because patients with such life threatening disease have decreased sexual interest; in addition hormonal treatment is associated with loss of sexual desire and function.
MP-6-6
Prevalence of sexual dysfunction and complaints in urological male patients I. Romics, Hungary; A. Rusz, G. Szombath
Introduction and Objectives The aim of this study was to examine the prevalence of sexual dysfunction (SD) among urological patients and to collect data about sexual characteristics and life satisfaction of our patients. Further goal was the evaluation of main underlying risk factors for erectile dysfunction (ED) and to assess patients and urologists attitude to SD.
Materials and Methods 400 anonymous questionnaires were given randomly in a half year period to the male patients older than 30 years in our general outpatient urological department The questionnaire included age, marital status, urological and other illnesses, diabetes, cardiovascular and neoplastic diseases, depression, concomitant medication. Questions were given about general well-being,life satisfaction, sexual performance, erectile function, libido, ejaculatory function and micturition. Severity of complaints were defined as mild, moderate severe and very severe Results 313 patients answered the questions (response rate 78%). Mean age was 62,5 ( range 31-91), majority (80%) older than 50 years. Decreased overall sexual performance and erectile dysfunction was answered in 77%, decreased libido in 73% of patients. Ejaculatory problems were reported by 64%, premature ejaculation experienced by 58%. 70% of patients complain for decreased volume of ejaculate. Surprisingly, despite of frequent complaints no one of patients answered that he has ED as an illness. No one reported use of sildenafil or any treatment for ED. Multiple risk factors for ED are found in majority of patients. 52% of patients need consultation and seek help for SD. Conclusions Prevalence of SD is high among urological patients. Despite of presence of experienced staff, SD and ED is not evaluated appropriately. Urological patients need more attention and care towards their sexual problems.
MP-6-7
Undiagnosed comorbidity in new erectile dysfunction patients B. Chappell, United Kingdom; V. Lehman, P. Thomas
Introduction and Objectives The aim of this study was to asses the level of undiagnosed comorbidity in new patients presenting to an erectile dysfunction clinic. Materials and Methods All new patients (41) over a 3 month period (median age 46: range 24-77) who presented to the erectile dysfunction clinic were assessed. An assessment of endocrine and cardiovascular status was made by recording blood pressure, urinalysis, fasting serum glucose, fasting serum cholesterol and serum testosterone. Results were reviewed at the follow up appointment and appropriate referrals were made. Results 41 patients were assessed. Of these 14 (35%) were hypertensive at time of sphygmomanometry, only 2 were undergoing therapy for hypertension. Urinalysis detected 1 undiagnosed urinary tract infection, 3 patients with proteinuria who were also hypertensive and 2 cases of asymptomatic microscopic haematuria. Glucose intolerance was noted in 2 (5%) patients. Hyperlipidaemia was detected in 9 (22%) of whom only 2 were on drug therapy. Only 1 patient was found to have a low testosterone, who displayed the stigmata of hypogonadism. Conclusions Undiagnosed comorbidity was detected in 48% of patients, these conditions hypertension, diabetes and hyperlipidaemia are all known risk factors for erectile dysfunction. Patients presenting with erectile dysfunction give primary care and hospital physicians the opportunity to detect undiagnosed comorbidity.
MP-6-8
Joint effect of hypertension, history of prostate disease and lower urinary tract symptoms (LUTS) on erectile dysfunction (ED)
A. Nicolosi, Italy; D. B. Glasser, M. Villa Objectives This study aims to estimate the joint effect of hypertension, prostate disease and LUTS on the prevalence of ED and at assessing the interaction between these factors. Methods We analyzed the data of the Cross National Study of the Prevalence of ED (CNS), and from a Turkish study using the same methodology, for a sample of 6,032 men aged 40 to 70 years. Structured questionnaires had been used to collect information. Men were classified as having moderate or complete ED if they reported they were sometimes or never able to achieve and maintain an erection satisfactory for sexual intercourse, respectively. LUTS were assessed by the International Prostate Symptoms Score (IPSS 7 ''absent or minor '', 8-19 ''moderate'' 419 ''severe''). Prostate conditions included BPH, history of prostatitis, prostate surgery or cancer. Odds ratios (OR), 95% confidence intervals (CI) and multivariate logistic regression were used to study associations. Results 1,473 men reported moderate or complete ED (age-standardized prevalence 24%). ED prevalence was 17% in men without any of the studied conditions, 25% in men with hypertension alone, 34.8% in men with moderate or severe LUTS or history of prostate disease alone, and 42.2% in men with hypertension and prostate disease or LUTS. At multivariate analysis, the OR for ED in men with hypertension alone was 1.7 (95% CI 1.4-2.1), the OR in men with prostate disease or LUTS alone was 2.7 (95% CI 2.1-3.4), and the OR in men with the presence of both hypertension and prostate disease or LUTS was 4.0 (95% CI 3.1-5.3). Conclusions Hypertension and prostate disease or LUTS increase the risk for ED in an additive manner, but the risk in men with both conditions is not higher than the sum of the single risks associated with hypertension alone and prostate disease or LUTS alone.
MP-6-9
Do sexual functions vary with severity of lower urinary tract symptoms suggestive of benign prostatic hyperplasia?
A. Tunckiran, Turkey; E. Akbay, M. Bozlu, S. Cayan, E. Ulusoy
Objective The aim of this study was to examine the effect of the severity of lower urinary tract symptoms (LUTS) on sexual functions in patients with benign prostatic hyperplasia (BPH). Patients and Methods In this prospective study, 101 men with BPH were enrolled and all patients had a routine prostatic evaluation, including digital rectal examination, prostate specific antigen level, prostatic volume and maximum flow rate. Symptoms were assessed using the Turkish validation of International Prostate Symptom Score (IPSS) and sexual functions using International Continence Society sex questionnaire (ICSsex) items concerned with erectile stiffness, ejaculatory volume, pain or discomfort on ejaculation, whether sex life was spoilt by urinary symptoms and their bothersomeness. Results Seventy six patients (75.3%) had moderate to severe urinary symptoms (IPSS 47). The rates of erectile and ejaculatory dysfunction and pain or discomfort on ejaculation were 67.3%, 45.5% and 27.%, respectively. Significant number of patients (74.3%) had the perception that sex life was spoilt by urinary symptoms. All sexual dysfunctions were reported to be highly problematic, paricularly for the severity of LUTS. Conclusions Our study demonstrated that the severity of LUTS has a significant impact on sexual functions in patients with BPH
MP-6-10
The incidence of erectile dysfunction in Italy A. Nicolosi, Italy; D. B. Glasser, M. Villa
Objectives Italy was part of the Crossnational Study of the Prevalence of ED (CNS). We followed-up the original sample to estimate the incidence of ED and identify risk factors and subgroups at higher probability of developing ED. Design and Methods In 1997-98, we had interviewed 600 men aged 40 to 70 years. Three years later the 600 subjects were contacted again and interviewed with a questionnaire which was similar to that used in the CNS and included medical, sociodemographic and lifestyle data. Subjects who reported a worsening in erectile function were considered as incident cases. Cumulative incidence, the number of incident cases divided by the total sample, was the estimate of the risk of worsening of ED function within three years. Association with covariates was assessed in terms of relative risk and 95% confidence intervals (CI). Multivariate models were used to adjust for covariates. Results We interviewed 360 men, 93 of whom (27.4%) reported a worsening of erectile function during the preceding 3 years. In particular, 46 and 5 of the 104 men without ED at baseline reported mild and moderate ED, respectively; 34 of the 172 men who had mild ED at baseline reported moderate ED; 8 of the 63 men with moderate ED at baseline reported complete ED. At multivariate analysis, the risk of acquiring or worsening ED was higher with increasing age (RR 2.2, 95% CI 1.2-4.1 in men 60-70 years old), current smoking (RR¼1.9, 95% CI 1.1-3.1) and lower income. Conclusions As expected, the incidence of ED increases as age increases but the figures would suggest that 60 years could be a threshold. The risk for ED also increases in men who smoke and in men with low income, an indicator of poorer life and health standards.
MP-6-11
Prevalence of sexual dysfunction among psychiatric inpatients -A fixed date multicenterstudy Introduction and Objectives The aim of the present study was to gather information about the epidemiology of sexual dysfunction in a population of psychiatric inpatients and to investigate possible relationships between underlying psychiatric illness and medication. Design and Methods We conducted a survey at six sites on a fixed day using a standardised and validated questionnaire recording psychiatric and somatic illnesses, medication and sexual function-ing. Results The sample consisted of 587 inpatients with addictive, psychotic and affective disorders and treatment with two or more psychoactive agents to be the most common. 74,4% of patients in the last group and 69,4% of those with monotreatment reported worsening of their sexual functioning with 'loss of desire' being most prominent. As expected customary psychiatric medication as reported by Montejo et al. (2001) or Clayton et al. (2002) was associated with sexual dysfunction but contrary to those former results mirtazapine was not an exception. Venlafaxine differed significantly from the other antidepressants as it was more as-sociated with sexual dysfunction. Referring to the prevalence of sexual dysfunction we found an order among the most prescribed agents descending as follows: Venlafaxine (n¼47), mirtazapine (n¼84), citalopram (n¼99), trimipramin (n¼35) and doxepine (n¼26). Conclusions Our data do not support a clear-cut distinction between a high prevalence of sexual dysfunction of SSRI treatment and low prevalence of mirtazapine (and others in psychiatric inpatients). So far it is unclear if the acute phase of the underlying illness or other not yet specified reasons can explain this discrepancy between our and i.e. Montejo´s data.
MP-6-12
The effects of equestrian riding on adult male genitalia A. Karabulut, Turkey; L. Emir, D. Erol, U. Kosar, A. Turgut
Objectives The aim of this study is to investigate the effects of equestrian riding on adult male genitalia. Design and Methods This study is based on comparison of two groups. The first group was consisted with 26 adult candidate males working as equestrian guard. The ages of the equestrian group were ranged between 26 and 38 (mean: 30.8). Each member of the group was riding horse every day for at least 2 hours time. The second, ''control'' group was consisted with 26 healthy adult males who had never ride horse before. The ages were ranged between 26 and 41 (mean: 30.6). Both groups were examined by the same urologist and radiologist. IIEF scores and complaints about genitourinary system were recorded and scrotal gray scale and color Doppler ultrasound analysis were performed for each member of the groups. These two groups were compared with each other by means of IIEF scores, genitourinary complaints, dimensions of testes and epididymides, presence of hydrocele, varicocele, epididymal cyst, testicular /epididymal calcification. Mann-Whitney U, Fisher's Exact and Pearson Chi Square tests were used for statistical analysis.
Results There were no statistically significant difference between the groups by means of testicular and epididymal dimensions, calcifications, IIEF scores and presence of genitourinary complaints. The presence of varicocele was significantly (po0.05), presence of hydrocele was marginally significantly (p¼0.051) higher in the equestrian group than the control group. Conclusions The results of the present study demonstrated that despite they had no genitourinary complaints, equestrian men are prone to have hydrocele and varicocele.
